Company patents
Veradermics, Incorporated
Veradermics, Incorporated's patent strategy is overwhelmingly concentrated in Pharmaceutical Preparations, representing 100.0% of its 81-patent portfolio, with a significant emerging focus on Therapeutic Activity (Pharma), which saw a remarkable 1400.0% growth in 2025 and an additional 50.0% increase so far in 2026. Surprisingly, despite its pharma focus, the company has completely shifted away from Drug Delivery Devices, with a 100.0% decline in patenting in 2025 and no new patents so far in 2026, indicating a strategic pivot away from device integration.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
81 US filings (since 2023) · 3 categories · 1 themes
Patents
Showing 1-10 of 82